BSX
Stock Details
BSX is Boston Scientific Corporation's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 40.22$. Average daily volumn in 3 months 8.88M. Market cap 53.79B
Stock symbol : BSX. Exchange : NYSE. Currency : USD Lastest price : 37.62$. Total volume : 5.30M. Market state REGULAR Click reload if you want to check the lastest price on market!!!
Boston Scientific Corporation (BSX)
Last Price
37.62$Change
-0.20Volume
5.30M
| Previous Close | 37.82 |
| Open | 38.04 |
| Day Range | 37.62-38.27 |
| Bid | 37.67 x 800 |
| Ask | 37.68 x 1.4k |
| Volume | 5.3M |
| Average Volume | 8.88M |
| Market Cap | 53.79B |
| Beta | 0.82 |
| 52 Week Range | 34.98-47.50 |
| Trailing P/E | 70.99 |
| Foward P/E | 18.72 |
| Dividend (Yield %) | N/A |
| Ex-Dividend Date | N/A |
Financial Details
Organization
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable c... ardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Market Cap:
53.79BRevenue:
11.89BTotal Assets:
32.23BTotal Cash:
1.93B
News about "Boston Scientific Corporation"
Boston Scientific Co. (NYSE:BSX) Shares Purchased by AdvisorNet Financial Inc
Source from : Defense World - 16 hours ago
AdvisorNet Financial Inc grew its position in Boston Scientific Co. (NYSE:BSX – Get Rating) by 1.7% in the 1st quarter, according to the company in its most recent filing with the Securities and ...See details»
Nordea Investment Management AB Sells 38,216 Shares of Boston Scientific Co. (NYSE:BSX)
Source from : Defense World - 16 hours ago
Nordea Investment Management AB reduced its position in shares of Boston Scientific Co. (NYSE:BSX – Get Rating) by 33.0% in the first quarter, according to its most recent filing with the Securities & ...See details»
State of Alaska Department of Revenue Cuts Stock Holdings in Boston Scientific Co. (NYSE:BSX)
Source from : ETF Daily News - 2 days ago
Boston Scientific Company Profile (Get Rating) Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It ...See details»
Boston Scientific To Purchase Majority Stake of M.I.Tech
Source from : medtechintelligence - 6 days ago
M.I.Tech is an innovator in nonvascular stent development, with product offerings that complement our existing stent portfolio.” ...See details»
Boston Scientific Announces Agreement to Purchase Majority Stake of M.I.Tech Co., Ltd from Synergy Innovation Co., Ltd
Source from : Business Insider - 13 days ago
Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into a definitive agreement with Synergy Innovation Co., Ltd, to purchase its majority stake (approximately 64 percent) of ...See details»
Boston Scientific Remembers Cofounder Pete Nicholas, 1941-2022
Source from : Endovascular Today - 8 days ago
In an extensive online tribute, Boston Scientific Corporation announced the death of Peter M. “Pete” Nicholas, the com ...See details»
Boston Scientific To Purchase Synergy Innovation Co.'s 64% Stake In M.I.Tech
Source from : Nasdaq - 13 days ago
Boston Scientific Corp. (BSX) has entered into a definitive agreement with Synergy Innovation Co., Ltd, to purchase its majority stake of M.I.Tech Co. a publicly traded Korean manufacturer and ...See details»
Boston Scientific to Buy 64% of M.I. Tech for About $230 Million >BSX
Source from : MarketWatch - 13 days ago
Boston Scientific Corp. on Wednesday agreed to buy the roughly 64% stake in Korean medical-device maker M.I. Tech Co. Ltd. held by Synergy Innovation Co. Ltd. for about $230 million, Boston Scientific ...See details»
Boston Scientific Buys Substantial Stake In Korean MedTech Player
Source from : YAHOO!Finance - 13 days ago
Boston Scientific Corporation (NYSE: BSX) has agreed to purchase Synergy Innovation Co Ltd's majority stake (~64%) of M.I.Tech Co Ltd, a publicly-traded Korean manufacturer, and distributor of medical ...See details»
Boston Scientific (BSX) to Broaden Stent Portfolio With Buyout
Source from : Nasdaq - 12 days ago
Boston Scientific Corporation BSX recently agreed to purchase the majority stake in M.I.Tech Co., Ltd from Synergy Innovation Co., Ltd. This latest investment is aimed at broadening Boston ...See details»
Comera Life Sciences taps Boston Scientific veteran for CFO role
Source from : cfodive - 12 days ago
Boston Scientific alum Michael Campbell will act as CFO for recently public life sciences Comera, taking the helm approximately one month following the company’s SPAC merger.See details»
Judge: Lawsuit against Boston police who allegedly beat George Floyd protesters can proceed
Source from : Boston.com - 7 hours ago
The lawsuit now enters the discovery phase, with the first trial date to be announced in the coming weeks. Read more at Boston.com.See details»
The Zacks Analyst Blog Highlights Adobe, The Southern Company, Northrop Grumman, Boston Scientific, Marathon Petroleum and Archer-Daniels-Midland
Source from : YAHOO!Finance - 5 days ago
Adobe, The Southern Company, Northrop Grumman, Boston Scientific, Marathon Petroleum and Archer-Daniels-Midland have been included in this Analyst Blog.See details»
Outlook on the Pacemaker Global Market to 2027 - Featuring Medtronic, Boston Scientific and Abbott Laboratories Among Others
Source from : Yahoo - 1 days ago
By Technology (Dual Chamber, Single Chamber, Biventricular Chamber), By Product Type, By Applications, By End User, By Region, Competition, Forecast & Opportunities, 2017-2027' report has been added ...See details»